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Abstract
Background: A cross-sectional study was carried out to determine the seroprevalence of different
serovars of Leptospira spp. and their association with clinical disease and host factors in Swedish horses.
Methods: Sera from 2017 horses brought to equine clinics during 1997–98 were investigated. The sera
were examined by microscopic agglutination test for the presence of antibodies against the following L.
interrogans serovars: Bratislava strain Jez, Icterohaemorrhagiae strain Kantorowicz and Pomona strain
Pomona and also L. kirschneri sv Grippotyphosa strain Duyster and L. borgpetersenii sv Sejroe strain M 84.
Host factors, disease factors, season, pasture access and outdoor confinement variables were analysed
with respect to seropositivity to sv Bratislava and Icterohaemorrhagiae. Multivariable logistic regression
was used to model seropositivity to sv Bratislava and Icterohaemorrhagiae (seroprevalence > 8%).
Results: The seroprevalence, at a cut-off 1:100, were for sv Bratislava (16.6%), Icterohaemorrhagiae
(8.3%), Sejroe (1.2%), Pomona (0.5%) and Grippotyphosa (0.4%). In the multivariable analysis, it was
demonstrated that seroprevalence increased with age for sv Bratislava and Icterohaemorrhagiae. For sv
Bratislava the seasons April – June and October – December and for sv Icterohaemorrhagiae October –
December had higher seroprevalences than other seasons. Horses not used for racing had higher levels
of seropositivity to sv Bratislava. Furthermore, horses with respiratory problems as well as horses with
fatigue had higher levels of seropositivity to sv Bratislava. Ponies and coldbloods, and horses with access
to pasture, had lower seroprevalence for sv Icterohaemorrhagiae. Healthy horses had lower
seroprevalence for sv Icterohaemorrhagiae, than non-healthy horses.
Conclusion: There was no significant association between clinical signs and disease and positive titres to
sv Bratislava (except for the association between respiratory problems and fatigue and seropositivity to sv
Bratislava). The results suggest that horses with increasing age and exposed to factors associated with
outdoor life had an increased seroprevalence for sv Bratislava, indicating that horses get infected from
outdoor and/or are exposed to shedding from other horses (management dependent). For sv
Icterohaemorrhagiae, management possibly plays a role as ponies and coldbloods as well as healthy horses
had lower seroprevalence. Overall, the age of the horse should be taken into consideration when
evaluating the titre as the average healthy horse has a higher titre than a young horse.
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Background
Leptospirosis is a serious worldwide, zoonotic infectious
disease of humans, domestic animals and wildlife, caused
by any of the pathogenic serovars (sv) within the genus
Leptospira (L.). Infection usually results from direct trans-
mission via contaminated urine or placental fluid, or indi-
rectly from a contaminated environment [1]. Clinical
manifestations of leptospirosis vary from acute to suba-
cute and chronic infection. Severe illness with jaundice,
haemoglobinuria, renal failure, meningitis and abortions
occur in domestic animals. Subclinical forms are perhaps
more common with chronically infected animals which
can be carriers for years to life [2].
Clinical infections have sometimes been observed in
horses [3]. The organism can cause uveitis [4-6], abortion
[7,8], stillbirth [9], prematurely born foals [10], renal dys-
function [11] and hepatic dysfunction [12]. Signs that
have been observed include haematuria [13], fever, jaun-
dice, anorexia [14-16], and respiratory distress [16].
Serological testing has been the traditional way of diag-
nosing leptospirosis in the laboratory. Microscopic agglu-
tination test (MAT) is the standard reference serological
test and a four-fold or greater change in antibody titres in
paired acute and convalescent sera is considered diagnos-
tic as well as a single finding of a high titre together with
clinical signs. Isolation of the spirochete is the ideal situa-
tion; however, it is a difficult, time-consuming task for
specialized reference laboratories [2]. In recent years,
polymerase chain reaction (PCR) specifically amplifying
leptospiral DNA has been used for demonstration of the
organism in tissue from prematurely born foals [10,17]
and in the vitreous aqueous humor of horses affected by
recurrent uveitis [4,6].
Serological evidence of leptospiral infection is common in
horses. Predominant serovars reported are L. interrogans sv
Pomona, L. interrogans sv Bratislava, L. interrogans sv Icter-
ohaemorrhagiae and L. kirschneri sv Grippotyphosa [3,18-
26]. In Sweden, although laboratory confirmation by
MAT, with a titre of ≥ 1:100, of any Leptospira serovar in
horses is notifiable [27], there is limited knowledge of
Leptospira seroprevalence in Swedish horses. Sometimes,
mature horses have been brought to veterinarians due to
vague clinical signs, e.g. poor performance or intermittent
fever and serological testing for antibodies to Leptospira
has been performed. Positive results have due to the lim-
ited knowledge sometimes been difficult to interpret,
which prompted us to perform this investigation.
The aims of the study were to estimate the seroprevalence
of several Leptospira  spp. in Swedish healthy and non-
healthy horses brought to equine clinics and to investigate
possible associations of seropositivity of the organism
with clinical disease status and host factors.
Materials and methods
Sampling procedure
A cross-sectional study was performed from 1 September
1997 to 3 September 1998 to determine the seropreva-
lence of five different serovars of Leptospira in horses. The
same material was used previously for an investigation of
seropositivity to Borrelia burgdorferi sensu lato and granu-
locytic  Ehrlichia  spp. (Anaplasma phagocytophilum) [28].
Blood samples were collected from horses brought to
major equine clinics (n = 17) affiliated to the Swedish
Horserace Totalizator Board. Each clinic was assigned at
random (by lottery) 2 days in each month when they sam-
pled horses up to a predetermined quota (3–19 each
month). The quota was directly proportional to the
number of cases examined at these clinics during the pre-
vious year. The purpose was to sample approximately
2000 horses. Sampling calculations were performed
mainly for the previous study [28].
All owners/trainers were informed and invited to partici-
pate. They completed a questionnaire regarding both the
horses' health status and host factors [28]. The clinic vet-
erinarians also answered questions about the horses'
health, most closed and semi-open, except for one open
question concerning the diagnosis. For this study, an
additional question was included in the questionnaire
regarding the occurrence of rodents in the stables (none,
few, many, not known). The questionnaires, together with
the blood samples, were sent to the National Veterinary
Institute, Uppsala, Sweden. Samples were centrifuged and
the sera were stored at -20°C until tested. The study was
approved by the Swedish Ethical Committee on Animal
Experiments.
Animals
A total of 2031 horses were sampled. Of these, samples
from 14 horses were excluded (12 lacked most of the
information required by the questionnaires and two
lacked a serum sample). A total of 2017 horses of different
breeds, age and sex were evaluated in the study (Table 1),
grouped healthy (n = 400) and non-healthy horses (n =
1617). The purpose of the visit, with various alternatives
such as disease, castration, pre-purchase examination,
vaccination, lameness, teeth floating or other, and the
clinical signs were recorded by the veterinarian.
Healthy horses (n = 400)
This group comprised horses that were considered entirely
fit for the task required and deemed healthy by the owner/
trainer at the time of sampling and also during the previ-
ous 12 months. Some horses (n = 251) were brought to
the clinics for procedures not associated with clinical dis-
ease such as vaccination, teeth floating, pre-purchase
examination and castration. Horses were included in the
group only if the veterinarian deemed the horse to be
healthy. Other horses (n = 149) brought to the clinic onlyActa Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
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Table 1: Distribution of seroprevalences for Leptospira interrogans serovars Bratislava and Icterohaemorrhagiae, cut-off 1:100, by 
breed, age, gender, usage, season, location, pasture access, outdoor confinement and occurrence of rodents in 2017 horsesa
% positive horses
Variable No. of tested horses sv Bratislava sv Icterohaemorrhagiae
Breed
Standardbred 912 8.7 6.6
Thoroughbred 137 16.8 5.8
Pony 174 27.0 9.2
Coldblood 157 19.1 4.5
Warmblood 637 24.5 12.1
Age (years)b
0–2 231 6.9 1.7
3–5 668 11.8 4.5
6–10 727 17.7 8.9
11–15 289 19.0 17.0
> 15 99 35.4 19.2
Gender
Mare 807 20.8 8.4
Gelding 916 16.6 9.7
Stallion 294 5.1 3.7
Usage
Trotting 964 8.2 6.0
Exercise 446 25.6 10.5
Competition riding 443 25.3 11.5
Riding school 106 24.5 15.1
Gallop 69 8.7 4.3
Breeding 57 29.8 7.0
Other 96 20.8 8.3
Season
January-March 514 11.3 7.0
April-June 507 21.9 6.3
July-September 483 16.1 9.1
October-December 513 17.2 10.9
Regionc
South 824 18.2 9.1
Middle 588 16.8 8.5
North 572 14.9 7.3
Pasture accessd
None 598 11.9 9.4
< 1 month 175 20.6 5.1
1–3 months 530 19.4 10.9
> 3 months 488 19.7 5.3
Outdoor confinement
None 23 8.7 0
Yard without grass 750 13.5 7.9
Field with grass 1248 17.9 9.0
Riding in terrain 369 21.1 9.5
Occurrence of rodentse
None 387 19.6 23.0
Few 1443 15.7 20.9
Many 52 17.3 19.2
Not known 123 18.7 23.6
aHorses were sampled during September 1997–98 from clinics associated with the Swedish Horserace Totalizator Board. bFor three horses, 
information on age was missing. cFor 33 horses, information on location was missing.dFor 226 healthy horses, information on pasture access was 
missing. eFor 12 horses, information on occurrence of rodents was missing.Acta Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
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for acute traumatic injuries were included in the healthy
group if they had been healthy during the previous year. It
was assumed that such injuries were unlikely to be associ-
ated with Leptospira infection.
Non-healthy horses (n = 1617)
The clinical signs, aetiology or procedures recorded were:
abortion, behavioural problems, colic, diarrhea, fatigue,
fever, inappetence, integumentary problems, lame 1 leg,
lame  ≥ 2 legs, ophthalmological disease, radiographic
examination (admitted for various problems to the
equine clinics by veterinarians in horse practice), respira-
tory signs, staggering, stiffness, tendon injuries, traumatic
injuries, unwillingness to be ridden or wasting (all
denoted as disease factors). Lameness was analysed for
one or for several limbs as well as for "any lameness", irre-
spective of the number of lame limbs. The variable "ten-
don injuries" represents only cases with clinically
confirmed tendon injuries. The variable "unwillingness to
be ridden" was analysed within the group of riding horses
(horses used for exercise, competition, or as riding school
horses and of pony or warmblood breeds).
Serological test to Leptospira
The 2017 sera were examined by MAT [2]. The antigens used
were live cultures of reference strains L. interrogans sv Bratisl-
ava, strain Jez (sv Bratislava); L. interrogans sv Icterohaemor-
rhagiae, strain Kantorowicz (sv Icterohaemorrhagiae); L.
kirschneri  sv Grippotyphosa, strain Duyster (sv Grippoty-
phosa);  L. interrogans sv Pomona, strain Pomona (sv
Pomona); and L. borgpetersenii sv Sejroe, strain M 84 (sv
Sejroe). These reference strains were obtained from the Royal
Tropical Institute in Amsterdam, The Netherlands. The sero-
vars tested for in this study represent a spectrum that was
expected to be prevalent among horses in Sweden, according
to an earlier study [19] and information gained by experi-
ence from testing of clinical samples at the diagnostic labora-
tory at the National Veterinary Institute, Uppsala.
All sera that gave a positive reaction at a 1:100 dilution
were further titrated in serial two-fold dilutions to titre
end-point, i.e. 50% agglutination [2]. A titre ≥ 1:100 was
deemed positive, i.e. indicating exposure to leptospires.
Quality control
Purity of the antigens used in the MAT was checked regu-
larly by microscopy. An evaluation of the identity of the
antigens against reference sera obtained from the Royal
Tropical Institute in Amsterdam, the Netherlands was per-
formed twice a year. The MAT was performed by one per-
son, to limit inter-observer variations of the test results.
Data analysis (description of variables, variable 
construction and data analysis)
Horses were considered as 0 years old during the year
born and one year the following year, etc. "Warmblood"
included mostly Swedish Warmbloods, while "cold-
bloods" included horses such as North-Swedish horses,
Icelandic horses, and Fiord horses. Owners/trainers cate-
gorized the usage of the horses into the following given
categories: 1) trotting competition, 2) gallop racing, 3)
competition riding (mainly dressage, show-jumping or 3-
day-eventing), 4) exercise riding, 5) breeding or 6) other
(open alternative). More than one option for usage could
be marked. According to the open option, several horses
were riding-school horses and this was therefore retained
as a category. The owners/trainers also answered ques-
tions about outdoor confinement, pasture access, and
known or suspected exposure to rodents (rats and mice)
during the most recent year, as well as the preceding year.
Descriptive analysis
The titre distributions for all six agents are presented
crudely. For sv Bratislava and Icterohaemorrhagiae (with
seroprevalence > 8%) titre distributions are also presented
according to whether the horses were considered healthy
or non-healthy. The numbers of horses tested and the
seroprevalence to sv Bratislava and Icterohaemorrhagiae
are presented crudely, by breed, age, gender, usage, region
(host factors), season, pasture access, outdoor confine-
ment and occurrence of rodents. Seroprevalences are pre-
sented for disease factors when at least 10 horses were
affected.
Multivariable analysis
Multivariable logistic regression was used (when sero-
prevalence was > 8%) to model two outcomes: titres ≥
1:100 to the agents sv Bratislava and Icterohaemorrhagiae
for associations with possible risk factors. For each out-
come one "disease model" was constructed, with 1982
observations, deleting observations with missing infor-
mation for either: breed, age, gender, racing (horses used
for trotting competition and gallop racing were referred to
in the multivariable analysis as "racing"), region or sea-
son. As risk factors in these models, breed, age, gender,
racing, region, season, health status and all disease factors
were considered (Table 2). For lameness it was decided to
model only lameness any limb. For each outcome, one
"pasture model" was further constructed where pasture
access and outdoor confinement were also included as
risk factors, containing 1763 observations (a number of
observations missing in these variables) (Table 3). A third
model was also tested: the "rodent model", where the
rodent variable was simply forced on the final disease
model (n = 1982).
The same baselines were selected for host and pasture var-
iables for both agents and all three models, selected on the
basis of lowest seroprevalence for both outcomes. For the
disease factors and outdoor confinement variables, the
baselines were simply absence of this clinical sign/dis-
ease/procedure/type of outdoor confinement. Age, whichActa Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
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was defined in whole years, was entered as a continuous
variable, after verifying that age could be adequately con-
sidered linearly related to the outcome for the sv Bratisl-
ava and Icterohemorrhagiae models.
The reduction process was as follows. Variables that had a
type 3 p-value < 0.2 remained in unreduced main effects
models. All possible two-way interactions were tested, one at
a time, upon the unreduced main effects models, and those
that proved significant at p ≤ 0.2 were retained for further
reduction. A final p-value of 0.05 was considered significant.
The Hosmer-Lemeshow test based on percentiles was used
for model validation. Over/under-dispersion was evalu-
ated using the ratio of the deviance to the number of
degrees of freedom. The SAS statistical software program
(SAS Institute Inc., Cary, NC 27513, USA) was used to
analyse the data, using the GENMOD procedure for logis-
tic regression. Ninety-five percent confidence intervals
(95% CI) for odds ratios (ORs) were constructed, taking
exponentials of βi ± 1.96 × SE.
Results
Seroprevalence
The highest seroprevalences for all investigated horses at a
cut-off 1:100 were found for sv Bratislava (16.6%) and Ict-
erohaemorrhagiae (8.3%). Leptospira seroprevalence and
titre distribution for all investigated serovars for all horses
are presented in Table 4. For sv Bratislava and Icterohaem-
orrhagiae, the seroprevalences for all horses by breed, age,
gender, usage, region (host factors), season, pasture
access, outdoor confinement and occurrence of rodents,
are presented in Table 1. The distribution of seropreva-
lences for non-healthy horses (n = 1617) for sv Bratislava
and Icterohaemorrhagiae by the disease factors asked are
presented in Table 5.
Multivariable analysis
The disease models
(Table 2) contained 1982 observations with 333 and 166
horses with titres positive to the respective agents: sv Bra-
tislava and Icterohaemorrhagiae. In the sv Bratislava
model, colic was omitted and in the sv Ictero-
haemorhagiae model, the interaction between breed and
season was omitted, both because of collinearity. The
ratio of deviance to degrees of freedom was 0.82 in the sv
Bratislava model and 0.52 in the sv Icterohaemorrhagiae
model, the latter indicating under-dispersion. The p-val-
ues from the Hosmer-Lemeshow tests were 0.54 and 0.20,
indicating well-fitting models. The rodent variable was
not significant in any model when included on the
reduced disease models.
Table 2: Multivariable results in the disease models for two different leptospira strains
Bratislava Icterohaemorrhagiae
Variable Category est se OR 95% CI est se OR 95%CI
Intercept -3.814 0.309 - - -3.478 0.243 - -
Age (continuous) 0.049 0.016 1.0 1.0, 1.1 0.150 0.020 1.2 1.1,1.2
Gender Mare 1.046 0.293 2.8 1.6, 5.1 NIM - - -
Gelding 0.687 0.295 2.0 1.1, 3.5 NIM - - -
Stallion 0 0 1.0 - NIM - - -
Breed Coldblood NIM - - - -1.026 0.452 0.4 0.1, 0.9
Warmblood NIM - - - -0.027 0.214 1.0 0.6, 1.5
Thoroughbred NIM - - - -0.462 0.409 0.6 0.3, 1.4
Pony NIM - - - -0.619 0.339 0.5 0.3, 1.0
Standardbred NIM - - - 0 0 1.0 -
Racing Not racing 0.982 0.164 2.7 1.9, 3.7 NIM - - -
Racing 0 0 1.0 - NIM - - -
Season Jan-Mar 0 0 1.0 - 0 0 1.0 -
Apr-June 0.722 0.185 2.1 1.4, 3.0 -0.234 0.261 0.8 0.5, 1.3
July-Sept 0.295 0.195 1.3 0.9, 2.0 0.290 0.244 1.3 0.8, 2.2
Oct-Dec 0.444 0.192 1.6 1.1, 2.3 0.581 0.235 1.8 1.1, 2.8
Health status Healthy NIM - - - -1.504 0.355 0.2 0.1, 0.4
Non-healthy NIM - - - 0 0 1.0 -
Respiratory problems Yes 0.572 0.263 1.8 1.1, 3.0 NIM - - -
No 0 0 1.0 - NIM - - -
Fatigue Yes 1.279 0.351 3.6 1.8, 7.1 NIM - - -
No 0 0 1.0 - NIM - - -
The outcome is a titre of ≥ 1:100 to the respective agents. There were 1982 observations with 333 and 166 horses with positive titres to the 
respective agents
NIM – not in model, est – estimate, se – standard error, OR – odds ratio, CI – confidence intervalActa Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
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The pasture models
(Table 3) contained 1763 observations with 304 and 150
horses with titres positive to the respective agents: sv Brati-
slava and Icterohaemorrhagiae. In these models the ratios
of deviance to degrees of freedom were 0.84 and 0.53 for
the respective agents, the ratio for the sv Icterohaemor-
rhagiae model indicated under-dispersion. The p-values
from the Hosmer-Lemeshow tests were 0.98 and < 0.001,
indicating that only the sv Bratislava model fitted the data
well. In the sv Icterohaemorrhagiae model, the largest pos-
itive deviance residuals approached 3, and were found for
young horses and horses sampled in April – June.
For sv Bratislava the disease model included three host
factors (age, gender, racing), season and health status
(Table 2). The pasture model included the same factors
Table 4: Number of serum samples from 2017 horsesa (healthy [n = 400] and non-healthy horsesb [n = 1617]) with titres to five 
Leptospira serovars obtained by microscopic agglutination test
Number (%) of positive horses at each titre
Seropositivec 1:100 1:200 1:400 1:800 1:1600 1:3200
Serovar n % n % n % n % n % n % n %
Bratislava 335 16.6 274 81.8 54 16.1 6 1.8 0 0 0 0 1 0.3
Healthy horses 65 16.3 49 75.4 14 21.5 2 3.1 0 0 0 0 0 0
Non-healthy horses 270 16.7 225 83.3 40 14.8 4 1.5 0 0 0 0 1 0.4
Icterohaemorrhagiae 168 8.3 101 60.1 41 24.4 16 9.5 7 4.2 2 1.2 1 0.6
Healthy horses 9 2.2 6 66.7 2 22.2 0 0 1 11.1 0 0 0 0
Non-healthy horses 159 9.8 95 59.7 39 24.5 16 10.1 6 3.8 2 1.3 1 0.6
Grippotyphosa 8 0.4 4 50.0 4 50.0 0 0 0 0 0 0 0 0
Pomona 11 0.5 8 72.7 0 0 3 27.3 0 0 0 0 0 0
Sejroe 24 1.2 15 62.5 5 20.8 3 12.5 0 0 0 0 1 4.2
aHorses were sampled during September 1997–98 from clinics associated with the Swedish Horserace Totalizator Board.
bHorses were grouped as healthy and non-healthy when the seroprevalence exceeded 8% at a cut-off 1:100. cAll horses with a titre ≥ 1:100
Table 3: Multivariable results in the pasture models for two different leptospira strains.
Bratislava Icterohaemorrhagiae
Variable Category est se OR 95% CI est se OR 95% CI
Intercept -3.616 0.385 - - -3.449 0.260 - -
Age, continuous 0.048 0.016 1.0 1.0, 1.1 0.149 0.019 1.2 1.1, 1.2
Gender Mare 0.812 0.376 2.3 1.1, 4.7 NIM - - -
Gelding 0.679 0.378 2.0 0.9, 4.1 NIM - - -
Stallion 0 0 1.0 - NIM - - -
Racing Not racing 1.045 0.183 2.8 2.0, 4.1 NIM - - -
Racing 0 0 1.0 - NIM - - -
Season Jan-Mar 0 0 1.0 - 0 0 1.0 -
Apr-June 0.802 0.198 2.2 1.5, 3.3 -0.349 0.283 0.7 0.4, 1.2
July-Sept 0.340 0.209 1.4 0.9, 2.1 0.374 0.256 1.5 0.9, 2.4
Oct-Dec 0.580 0.203 1.8 1.2, 2.7 0.652 0.246 1.9 1.2, 3.1
Paddock Yes -0.120 0.580 0.9 0.3, 2.8 NIM - - -
No 0 0 1.0 - NIM - - -
Riding in terrain Yes 0.702 0.414 2.0 0.9, 4.5 NIM - - -
No 0 0 1.0 - NIM - - -
Pasture None NIM - - - 0 0 1.0 -
< 1 month NIM - - - -1.010 0.380 0.4 0.2, 0.8
1 < 3 months NIM - - - -0.239 0.212 0.8 0.5, 1.2
> 3 months NIM - - - -0.965 0.260 0.4 0.2, 0.6
Interactions
Paddock * Gender Paddock, mare 0.296 0.164 1.3 1.0, 1.9 NIM - - -
Paddock, gelding -0.490 0.620 0.6 0.2, 2.1 NIM - - -
Riding in terrain * Racing Riding in terrain, Not racing -1.070 0.449 0.3 0.1, 0.8 NIM - - -
The outcome is a titre of ≥ 1:100 to the respective agents. There were 1763 observations with 304 and 150 horses with positive titres to the 
respective agents.
NIM – not in model, est – estimate, se – standard error, OR – odds ratio, CI – confidence interval.Acta Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
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and also "paddock" and "riding in terrain", but not health
status (Table 3). In both the disease and pasture models it
was found that seroprevalence increased with age and that
the seasons April – June and October – December had
higher seroprevalences than other seasons. With respect to
genders, mares and geldings had higher odds ratios (ORs)
than stallions in the disease model. However, there was an
interaction with paddock in the pasture model, indicating
that mares in paddocks had a slightly higher seropreva-
lence than geldings in paddocks. The main effect of "non-
racing" was similar in both models (ORs 2.8 and 2.7).
However, "non-racing" interacted with "riding in terrain"
in the pasture model, with a low OR for individuals hav-
ing both these attributes (0.3). "Respiratory problem"
yielded an OR of 1.8 and "fatigue" was associated with an
OR of 3.6 with respect to seropositivity in the disease
model.
The sv Icterohaemorrhagiae disease model included two
host factors (breed, age), season and health status (Table
2). The pasture model included one host factor (age), plus
season and pasture (Table 3). In both disease and pasture
models, seropositivity increased with age and the sero-
prevalence was higher in October – December than for
other seasons. Only the disease model contained "breed",
where coldbloods and ponies had lower levels of seropos-




These serum samples were previously used to study the
seroprevalence to Borrelia burgdorferi sensu lato and granu-
locytic  Ehrlichia  spp. (Anaplasma phagocytophilum) [28].
Several issues in that paper are relevant also for the
present study. For example, the population including
both healthy and diseased horses is not a cross-section of
the Swedish horse population. More horses with some
kind of problems are seen than in the base population
and competition horses as well as active sport horses are
probably overrepresented, while foals, brood-mares and
stallions used for breeding are probably underrepre-
sented. However, the stratified and multivariable
approaches compensate for this problem to some degree,
making possible estimation of odds ratios (ORs) and per-
centages relevant to subgroups. We cannot say whether
the clinical signs preceded the titres or vice versa. Seropos-
itivity is not a pretext for an ongoing disease but a measure
of exposure. In our cross-sectional study, we don't know if
the horses with titres developed clinical signs later. One
further problem was the relatively large number of miss-
ing values for the questions concerning pasture access.
Also, we believe that the answers to the rodent exposure
questions might not have accurately reflected the rodent
situation on the premises. This was because the ques-
tioned person was probably often not the person best
acquainted with rodent density and further there might
Table 5: Distribution of seroprevalences (%) for Leptospira interrogans serovars Bratislava and Icterohaemorrhagiae, cut-off 1:100, by 
the clinical/etiological categories/procedures asked for among non-healthy horses (n = 1617)a
% positive horses
Disease factor No. of horses with clinical signs sv Bratislava sv Icterohaemorrhagiae
Sign, etiology or procedureb
Behavioral problems 23 21.7 13.0
Colic 15 0 6.7
Fatigue 48 31.3 14.6
Fever 13 7.7 7.7
Inappetence 19 31.6 10.5
Integumentary problems 31 16.1 12.9
Lameness, any 905 17.2 10.5
Lame 1 limb 513 17.3 10.5
Lame ≥ 2 limbs 392 17.1 10.5
Radiographic examinationc 24 8.3 4.2
Respiratory signs 113 20.4 9.7
Staggering 10 20.0 0
Stiffness 49 22.4 8.2
Tendon injuries 70 17.1 12.9
Unwillingness to be ridden 49 24.5 10.2
Wasting 24 20.8 4.2
aHorses sampled during September 1997–98 from clinics associated with the Swedish Horserace Totalizator Board. bAbortion, ophthalmological 
diseases and diarrhea were excluded from the clinical signs, etiological categories and/or procedures because < 10 horses were said to have been 
affected. Cases of septic arthritis were excluded from the joint problems. cAdmitted for various problems to the equine clinics by veterinarians in 
horse practice.Acta Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
Page 8 of 10
(page number not for citation purposes)
also be differences regarding interpretation of rodent den-
sity.
During the investigation, two different strains of sv Brati-
slava were used as antigens, the reference strain Jez and a
laboratory strain of unknown origin. We included the lat-
ter as it had been used earlier to investigate samples in the
routine diagnostics at our laboratory and there had then
been a tendency to "high" seroprevalence with this strain
(unpublished observations) and sometimes difficulties in
interpreting the results. It was demonstrated that the over-
all seroprevalence for the investigated horses was consid-
erably higher for the laboratory strain (34.8%) than for
the reference strain Jez (16.6%), Ellis et al. [3] also found
differing seroprevalences for horses investigated with dif-
ferent antigens of sv Bratislava. However, the laboratory
strain was not included in this study as it was not a refer-
ence strain. We conclude that use of different strains as
antigen for a serovar can give differing seroprevalences.
For correct and meaningful comparisons between studies
it is therefore important to use the same reference strain as
antigen, also suggested by Ellis et al. [3].
Seroprevalence, host factors, pasture and outdoor 
confinement factors
The seroprevalence for the horses in this study was highest
for sv Bratislava. Also, in other investigations the seroprev-
alence was higher for sv Bratislava than for other serovars
and the horse has been suggested to be a maintenance
host for this serovar [3,16,20,29]. For both sv Bratislava
and Icterohaemorrhagiae, seropositivity increased with
age. The same has also been reported by others
[20,21,29,30]. It is likely that horses, during their life-
span, encounter leptospires from the environment or
from other horses and titres can persist for a long time.
With respect to gender, mares and geldings had, com-
pared with stallions, a higher OR of seropositivity to sv
Bratislava in the disease model. Also, horses not used for
racing had a higher OR of seropositivity to sv Bratislava in
both models. One interpretation could be that stallions
and racing horses are more often kept individually and
may therefore be less exposed to shedding from other
horses. Management may differ too. In a study by Lees
and Gale [30], it was shown that track horses that were
managed individually had lower ORs than rodeo horses
that were managed in groups, for all investigated serovars
including sv Bratislava and Icterohaemorrhagiae. In our
study we did not ask whether horses were kept individu-
ally or in groups.
Breed was significant in the disease model, where interest-
ingly ponies and coldbloods had a lower OR of seroposi-
tivity to sv Icterohaemorrhagiae. One explanation could
be that in the summer, grazing horses do not come into
contact with other kinds of feed or material that may be
contaminated by urine from small rodents. Maybe some
breeds, e.g. coldblood and ponies, usually have greater
access to pasture than other breeds and therefore are less
exposed to rodents in the stable in the summer. Also,
management factors can differ between breeds. For sv Ict-
erohaemorrhagiae the maintenance host is the rat, which
serves a as reservoir of infection [1]. In this study, there
was no correlation between exposure to rodents and sero-
prevalence for Leptospira and in the multivariable models
rodents were removed for both investigated serovars.
In the study by Barwick et al. [31], soil and water index
were the only factors associated with the risk of exposure
to all investigated serovars. In Europe, the hedgehog is
known as a wildlife host of sv Bratislava [32]. In this
study, we did not take into account the variation in wild-
life or access to stagnant water, e.g. in ponds. In the pas-
ture model for sv Bratislava, there was an interaction
between "riding in terrain" and the "racing" variables.
Combining the estimates in this interaction and using rac-
ing horses not ridden (trained) in terrain as the baseline
(OR = 1), all other categories had OR point estimates ≥ 2.
The highest point estimate was found for non racing
horses not ridden in terrain (OR = 2.8), the findings from
this interaction being difficult to explain. A hypothesis
may be that horses living close to cities are ridden in the
terrain less and may become more exposed to shedding
from other horses due to kept on smaller areas per horse
than horses out in the country.
Furthermore, in the pasture model, there was an interac-
tion between mares and paddocks (yard without grass).
Judging from the combined estimates using stallions with
no paddock as baseline, indicated that mares that were
kept in paddocks (exp(0.812-0.120+0.296) = OR 2.7) had a
higher seroprevalence than geldings in paddocks (OR =
1.1), the gender difference being smaller when both these
genders did not specifically have access to paddocks (data
not shown). This interaction too is difficult to explain.
Season
The present study indicates seasonal variations in lept-
ospiral titres in both models. For sv Icterohaemorrhagie,
horses had the highest seroprevalence in October –
December. Small rodents living in the wild usually invade
stables and houses in late summer and autumn, which
can give an increased infection incidence during this
period. For sv Bratislava the highest seroprevalence was
found in April – June and also October – December. Mois-
ture, moderately warm temperature and neutral or mildly
stagnant water are essential for survival of the organism in
the environment [1]. Probably most horses get infected
during the warmer season, in spring and summer. The
separate peak in October-December may be explained byActa Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
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that horses are usually regrouped in the beginning of the
autumn when taken from pasture to paddocks. They may
then be exposed to shedding from new horses when they
infect each other. Seasonal variation has also been
reported for other animal species in other countries e.g.
pigs in Vietnam [33].
Disease factors
In the disease model, serum antibody titres to sv Bratisl-
ava and Icterohaemorrhagie were not generally associated
with the disease factors included in this study, with two
exceptions: horses with fatigue and also horses with respi-
ratory problems had higher levels of seropositivity to sv
Bratislava. In a study by Van der Ingh et al. [16], fever and
respiratory distress were observed in foals with leptospiro-
sis and it was suggested that leptospiral infection was
spread by direct contact between the horses in the out-
break. Moreover, it was demonstrated for sv Icterohaem-
orrhagiae that healthy horses had lower levels of
seropositivity than non-healthy horses. The explanation
may be that factors that promote equine health also pro-
tect against infection of Leptospira  spp, which is why
healthy horses are less susceptible. In Sweden, the clinical
disease of leptospirosis in horses is seldom diagnosed
though serological reactions – especially to sv Bratislava
and also Icterohaemorrhagiae – are sometimes found.
Conclusion
From a clinical point of view, this study showed that there
was no significant association between clinical signs and
disease and positive titres to sv Bratislava or Icterohaem-
orrhagiae (except for the association between respiratory
problems and fatigue and seropositivity to sv Bratislava).
The results of this study suggest that horses with increas-
ing age and exposed to factors associated with outdoor life
had an increased seroprevalence for sv Bratislava, indicat-
ing that horses get infected from outdoor and/or are
exposed to shedding from other horses i.e. related to man-
agement. For sv Icterohaemorrhagiae, management possi-
bly plays a role as ponies and coldbloods as well as
healthy horses had lower seroprevalence. Overall, the age
of the horse should be taken into consideration when
evaluating the titre as the average healthy horse has a
higher titre than a young horse.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
VB is the main author of the paper. All authors (VB, AE,
PF, AG, EOE) contributed to the design of the study. PF
was in charge of collecting all clinical information and
blood sampling. VB was responsible for the laboratory
investigations. AE conducted the statistical analysis of this
paper. VB participated in the statistical analysis. VB
drafted the manuscript in collaboration with AE. All
authors read and approved the final manuscript.
Acknowledgements
Ulla-Britt Wikström is acknowledged for excellent laboratory support. This 
research was supported by the AGRIA Foundation for Research and the 
Swedish Horserace Totalizator Board. We are extremely grateful to the 
veterinarians and technical staff at the clinics affiliated to the Board for fruit-
ful cooperation and for sampling horses and submitting questionnaires.
References
1. Bolin C: Leptospirosis.  In Emerging Diseases of Animals Edited by:
Brown C, Bolin C. ASM Press, American Society for Microbiology,
Washington DC; 2000:185-200. 
2. OIE: Leptospirosis.  In Manual of Diagnostic Tests and Vaccines for Ter-
restrial Animals Volume 1. 5th edition. OIE Biological Standards Com-
mission and adopted by the International Committee of the OIE.
Office International des epizooties. Paris, France; 2004:316-27. 
3. Ellis WA, O'Brien JJ, Cassells JA, Montgomery J: Leptospiral infec-
tion in horses in Northern Ireland: serological and microbio-
logical findings.  Equine Vet J 1983, 15:317-20.
4. Faber NA, Crawford M, LeFebvre RB, Buyukmihci NC, Madigan JE,
Willits NH: Detection of Leptospira spp. in the aqueous humor
of horses with naturally acquired recurrent uveitis.  J Clin
Microbiol 2000, 38:2731-3.
5. Hartskeerl RA, Goris MG, Brem S, Meyer P, Kopp H, Gerhards H,
Wollanke B: Classification of leptospira from the eyes of
horses suffering from recurrent uveitis.  J Vet Med B Infect Dis
Vet Public Health 2004, 51:110-5.
6. Brandes K, Wollanke B, Niedermaier G, Brem S, Gerhards H: Recur-
rent uveitis in horses: vitreal examinations with ultrastruc-
tural detection of leptospires.  J Vet Med A Physiol Pathol Clin Med
2007, 54:270-5.
7. Ellis WA, O'Brien JJ, Cassells JA, Montgomery J: Leptospiral infec-
tion in aborted equine foetuses.  Equine Vet J 1983, 15:321-4.
8. Bernard WV, Bolin C, Riddle T, Durando M, Smith BJ, Tramontin RR:
Leptospiral abortion and leptospiruria in horses from the
same farm.  J Am Vet Med Assoc 1993, 202:1285-6.
9. Donahue JM, Smith BJ, Redmon KJ, Donahue JK: Diagnosis and
prevalence of leptospira infection in aborted and stillborn
horses.  J Vet Diagn Invest 1991, 3:148-51.
10. Vemulapalli R, Langohr IM, Sanchez A, Kiupel M, Bolin CA, Wu CC,
Lin TL: Molecular detection of Leptospira kirschneri in tissues
of a prematurely born foal.  J Vet Diagn Invest 2005, 17:67-71.
11. Divers TJ, Byars TD, Shin SJ: Renal dysfunction associated with
infection of Leptospira interrogans in a horse.  J Am Vet Med Assoc
1992, 201:1391-2.
12. Hathaway SC, Little TW, Finch SM, Stevens AE: Leptospiral infec-
tion in horses in England: a serological study.  Vet Rec 1981,
108:396-398.
13. Bernard WV, Williams D, Tuttle PA, Pierce S: Hematuria and lept-
ospiruria in a foal.  J Am Vet Med Assoc 1993, 203:276-8.
14. Hall CE, Bryans JT: A case of leptospirosis in a horse.  Cornell Vet
1952, 44:345-348.
15. Roberts SJ, York CJ, Robinson JW: An outbreak of leptospirosis
in horses on a small farm.  J Am Vet Med Assoc 1952, 121:237-242.
16. van den Ingh TS, Hartman EG, Bercovich Z: Clinical Leptospira
interrogans serogroup Australis serovar lora infection in a stud
farm in The Netherlands.  Vet Q 1989, 11:175-82.
17. Leon A, Pronost S, Tapprest J, Foucher N, Blanchard B, Andre-Fon-
taine G, Laugier C, Fortier G, Leclercq R: Identification of patho-
genic Leptospira strains in tissues of a premature foal by use
of polymerase chain reaction analysis.  J Vet Diagn Invest 2006,
18:218-21.
18. Verma BB, Biberstein EL, Meyer ME: Serologic survey of leptospi-
ral antibodies in horses in California.  Am J Vet Res 1977,
38:1443-4.
19. Sandstedt K, Engvall A: Serum antibodies to Leptospira bratisl-
ava in Swedish pigs and horses.  Nord Vet Med 1985, 37:312-313.
20. Kitson-Piggot AW, Prescott JF: Leptospirosis in horses in
Ontario.  Can J Vet Res 1987, 51:448-451.
21. Barwick RS, Mohammed HO, McDonough PL, White ME: Risk fac-
tors associated with the likelihood of leptospiral seropositiv-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Acta Veterinaria Scandinavica 2009, 51:15 http://www.actavetscand.com/content/51/1/15
Page 10 of 10
(page number not for citation purposes)
ity in horses in the state of New York.  Am J Vet Res 1997,
58:1097-103.
22. Barwick RS, Mohammed HO, Atwill ER, McDonough PL, White ME:
The prevalence of equine leptospirosis in New York State.  J
Equine Sci 1998, 9:119-124.
23. Cerri D, Ebani VV, Fratini F, Pinzauti P, Andraeani E: Epidemiology
of leptospirosis: observations on serological data obtained by
a "diagnostic laboratory for leptospirosis" from 1995 to
2001.  New Microbiol 2003, 26:383-9.
24. Rocha T, Ellis WA, Montgomery J, Gilmore C, Regalla J, Brem S:
Microbiological and serological study of leptospirosis in
horses at slaughter: first isolations.  Res Vet Sci 2004,
76:199-202.
25. Odontsetseg N, Boldbaatar D, Mweene AS, Kida H: Serological
prevalence of Leptospira interrogans serovar Bratislava in
horses in Mongolia.  Vet Rec 2005, 157:518-9.
26. Hashimoto VY, Goncalves DD, Silva FG, Oliveira RC, Alves LA,
Reichmann P, Muller EE, Freitas JC: Occurrence of antibodies
against Leptospira spp. in horses of the urban area of Lond-
rina, Paraná, Brazil.  Rev Inst Med Trop Sao Paulo 2007, 49:327-30.
27. Swedish Board of Agriculture, SJVFS 2007:90 Saknr K 4.  .
28. Egenvall A, Franzen P, Gunnarsson A, Olsson Engvall E, Vågsholm I,
Wikström U-B, Artursson K: Cross-sectional study of the sero-
prevalence status to Borrelia burgdorferi sensu lato and gran-
ulocytic  Ehrlichia  spp. and demographic, clinical and tick-
exposure factors in Swedish horses.  Prev Vet Med 2001,
49:191-208.
29. Park YG, Gordon JC, Bech-Nielsen S, Slemons RD: Factors for
seropositivity to leptospirosis in horses.  Prev Vet Med 1992,
13:121-127.
30. Lees VW, Gale SP: Titres to Leptospira species in horses in
Alberta.  Can Vet J 1994, 35:636-40.
31. Barwick RS, Mohammed HO, McDonough PL, White ME: Epidemi-
ologic features of equine Leptospira interrogans of human sig-
nificance.  Prev Vet Med 1998, 36:153-65.
32. Hartskeerl RA, Terpstra WJ: Leptospirosis in wild animals.  Vet Q
1996, 18(Suppl 3):S149-50.
33. Boqvist S, Ho Thi VT, Magnusson U: Annual variations in Lept-
ospira  seroprevalence among sows in southern Vietnam.
Trop Anim Health Prod 2005, 37:443-9.